<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-135131" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Stenotrophomonas Maltophilia</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Said</surname>
            <given-names>Mina S.</given-names>
          </name>
          <aff>Rochester General Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tirthani</surname>
            <given-names>Ekta</given-names>
          </name>
          <aff>Rochester General Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Lesho</surname>
            <given-names>Emil</given-names>
          </name>
          <aff>Rochester Regional Health</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Mina Said declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ekta Tirthani declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Emil Lesho declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>12</day>
          <month>6</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-135131.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Stenotrophomonas maltophilia is one of the less known drug-resistant bacteria that can cause challenging infections. This activity reviews the epidemiology of this organism as well as the risk factors of developing these infections. It also illustrates the pathophysiology and virulence factors of this pathogen and its relation with the clinical picture. It describes the modern evaluation and up-to-date treatment for the infections caused by this organism, as well as their estimated prognosis. Further, it highlights the role of the interprofessional team in case management.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Review the risk factors for developing Stenotrophomonas maltophilia infections.</p></list-item><list-item><p>Describe the epidemiology and statistical data of Stenotrophomonas maltophilia infections.</p></list-item><list-item><p>Outline the evaluation of Stenotrophomonas maltophilia infection cases and the challenges encountered.</p></list-item><list-item><p>Summarize the recommended treatment by interprofessional team and prevention modalities for Stenotrophomonas maltophilia infections.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=135131&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=135131">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-135131.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p><italic toggle="yes">Stenotrophomonas maltophilia</italic> is a gram-negative bacillus, initially called <italic toggle="yes">Bacterium bookeri,</italic> when it was first identified in 1943 from a specimen of human pleural fluid.<xref ref-type="bibr" rid="article-135131.r1">[1]</xref>&#x000a0;It was later classified as <italic toggle="yes">Pseudomonas maltophilia</italic> in 1961, then reassigned to the gammaproteobacteria class as <italic toggle="yes">Xanthomonas maltophilia</italic> in 1983, and eventually classified as a Stenotrophomonas in 199.<xref ref-type="bibr" rid="article-135131.r2">[2]</xref><xref ref-type="bibr" rid="article-135131.r3">[3]</xref><xref ref-type="bibr" rid="article-135131.r4">[4]</xref>&#x000a0;The name has Greek roots meaning &#x0201c;The narrow feeder - that loves malt.&#x0201d; The whole-genome sequence of representative isolate K279a genome sequence was published in 2008.<xref ref-type="bibr" rid="article-135131.r5">[5]</xref><xref ref-type="bibr" rid="article-135131.r6">[6]</xref></p>
        <p><italic toggle="yes">S. maltophilia</italic> can be considered a &#x0201c;newly emerging pathogen of concern&#x0201d; that is being isolated more frequently.<xref ref-type="bibr" rid="article-135131.r7">[7]</xref><xref ref-type="bibr" rid="article-135131.r8">[8]</xref><xref ref-type="bibr" rid="article-135131.r9">[9]</xref>&#x000a0;It is also recognized as one of the underestimated important multi-drug resistant organisms in hospitals by the World Health Organization (WHO).<xref ref-type="bibr" rid="article-135131.r10">[10]</xref><xref ref-type="bibr" rid="article-135131.r11">[11]</xref>&#x000a0;It was ranked as the ninth most important one per British microbiologists and one of the challenging pathogens in the infectious disease community and studies.<xref ref-type="bibr" rid="article-135131.r12">[12]</xref><xref ref-type="bibr" rid="article-135131.r2">[2]</xref>&#x000a0;It is widely known as an opportunistic organism associated with high morbidity and mortality rates among immunocompromised patients.</p>
      </sec>
      <sec id="article-135131.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p><italic toggle="yes">Stenotrophomonas maltophilia,</italic>&#x000a0;a non-fermenting gram-negative rod, is the third most common after <italic toggle="yes">Pseudomonas aeruginosa</italic> and <italic toggle="yes">Acinetobacter</italic>&#x000a0;and similar to <italic toggle="yes">Achromobacter xylosoxidans</italic> and <italic toggle="yes">Burkholderia cepacia.</italic><xref ref-type="bibr" rid="article-135131.r13">[13]</xref><xref ref-type="bibr" rid="article-135131.r4">[4]</xref><xref ref-type="bibr" rid="article-135131.r9">[9]</xref>&#x000a0;It is the only species among the seventeen of the Stenotrophomonas genus that infects man.<xref ref-type="bibr" rid="article-135131.r14">[14]</xref></p>
        <p>Risk factors for this infection include chronic respiratory diseases, especially cystic fibrosis, hematologic malignancy, chemotherapy-induced neutropenia, organ transplant patients, human immunodeficiency virus (HIV) infection, hemodialysis patients, and neonates.<xref ref-type="bibr" rid="article-135131.r9">[9]</xref><xref ref-type="bibr" rid="article-135131.r11">[11]</xref><xref ref-type="bibr" rid="article-135131.r15">[15]</xref><xref ref-type="bibr" rid="article-135131.r16">[16]</xref>&#x000a0;Also, hospital settings, prolonged intensive care unit stays, mechanical ventilation, tracheostomies, central venous catheters, severe traumatic injuries, significant burns, mucositis or mucosal barrier damaging factors, and the use of broad-spectrum antibiotic courses were shown to increase the risk of infection.<xref ref-type="bibr" rid="article-135131.r9">[9]</xref><xref ref-type="bibr" rid="article-135131.r17">[17]</xref>&#x000a0;</p>
        <p>These empiric broad-spectrum antimicrobials usually do not cover this particular pathogen, especially carbapenems, although no specific predominance was identified with them over other antimicrobials.<xref ref-type="bibr" rid="article-135131.r18">[18]</xref>&#x000a0;The risk from antibiotic exposure varies directly with both the duration and number of antimicrobials used.<xref ref-type="bibr" rid="article-135131.r8">[8]</xref></p>
      </sec>
      <sec id="article-135131.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p><italic toggle="yes">Stenotrophomonas maltophilia</italic>&#x000a0;prevalent.<xref ref-type="bibr" rid="article-135131.r2">[2]</xref>&#x000a0;It is frequently isolated in the environment, particularly from water bodies like rivers, wells, and lakes, also bottled water, sewage,&#x000a0;swine/chicken feces, soil, plants, salads, frozen fish, and raw milk.<xref ref-type="bibr" rid="article-135131.r2">[2]</xref><xref ref-type="bibr" rid="article-135131.r8">[8]</xref><xref ref-type="bibr" rid="article-135131.r17">[17]</xref><xref ref-type="bibr" rid="article-135131.r19">[19]</xref>&#x000a0;It has also been isolated from animals, especially aquatic species, with some of those animal isolates found to be within the same genogroups as the human strains, suggesting the possibility of strain or gene exchange with the human infection-causing isolates.<xref ref-type="bibr" rid="article-135131.r9">[9]</xref><xref ref-type="bibr" rid="article-135131.r20">[20]</xref>&#x000a0;Specific isolates are being utilized for the biosynthesis of organic compounds or their degradation, plant growth promotion against agricultural fungal pathogens, and bioremediation of soil or water.<xref ref-type="bibr" rid="article-135131.r21">[21]</xref><xref ref-type="bibr" rid="article-135131.r6">[6]</xref><xref ref-type="bibr" rid="article-135131.r22">[22]</xref><xref ref-type="bibr" rid="article-135131.r23">[23]</xref><xref ref-type="bibr" rid="article-135131.r24">[24]</xref></p>
        <p>More importantly, it can be found in multiple healthcare settings, such as hospital tap water faucets, sinks, shower outlets, air-cooling systems, ice-making and soda fountain machines, disinfectant solutions, intravenous fluids, catheters, ethylenediaminetetraacetic acid (EDTA) containing blood collection tubes, blood gas analyzers, dialysis machines, intra-aortic balloon pumps, nebulizers, oxygen humidifiers, breathing circuits, scopes, dental equipment, lens care systems, and the hands of healthcare workers.<xref ref-type="bibr" rid="article-135131.r18">[18]</xref><xref ref-type="bibr" rid="article-135131.r2">[2]</xref><xref ref-type="bibr" rid="article-135131.r17">[17]</xref><xref ref-type="bibr" rid="article-135131.r21">[21]</xref><xref ref-type="bibr" rid="article-135131.r22">[22]</xref><xref ref-type="bibr" rid="article-135131.r25">[25]</xref>&#x000a0;</p>
        <p>Most <italic toggle="yes">Stenotrophomonas maltophilia</italic> infections are, in fact, nosocomial, and many outbreaks have been reported within the previous years in hospitals and intensive care units.<xref ref-type="bibr" rid="article-135131.r26">[26]</xref><xref ref-type="bibr" rid="article-135131.r27">[27]</xref><xref ref-type="bibr" rid="article-135131.r26">[26]</xref>&#x000a0;Studies have proven genomic diversity among nosocomial infection isolates, which strongly suggests multiple independent environmental sources of transmission, though the patient-to-patient transmission has also been reported.<xref ref-type="bibr" rid="article-135131.r28">[28]</xref><xref ref-type="bibr" rid="article-135131.r29">[29]</xref></p>
        <p><italic toggle="yes">Stenotrophomonas maltophilia</italic> is estimated to be the most common carbapenem-resistant gram-negative bacterial cause of bloodstream infections in US hospitals, causing about 1% of nosocomial bacteremia cases.<xref ref-type="bibr" rid="article-135131.r30">[30]</xref><xref ref-type="bibr" rid="article-135131.r31">[31]</xref>&#x000a0;The incidence of infection cases is estimated to be from 5.7 to 37.7 cases per 10 thousand hospital discharges, which has been progressively higher than previously reported over the last decades since the 1970s.<xref ref-type="bibr" rid="article-135131.r32">[32]</xref><xref ref-type="bibr" rid="article-135131.r33">[33]</xref><xref ref-type="bibr" rid="article-135131.r34">[34]</xref><xref ref-type="bibr" rid="article-135131.r35">[35]</xref><xref ref-type="bibr" rid="article-135131.r36">[36]</xref>&#x000a0;This rising infection rate is believed to be primarily due to the increase in the number of immunocompromised patients and the wide use of broad-spectrum antibiotics.</p>
      </sec>
      <sec id="article-135131.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Although previously thought to have limited virulence, <italic toggle="yes">Stenotrophomonas maltophilia</italic> has shown to possess different powerful virulence factors that are believed to be present in all environmental isolates without any specific evolutionary branching, similar to <italic toggle="yes">Pseudomonas aeruginosa.</italic><xref ref-type="bibr" rid="article-135131.r18">[18]</xref><xref ref-type="bibr" rid="article-135131.r22">[22]</xref><xref ref-type="bibr" rid="article-135131.r37">[37]</xref></p>
        <p>The first noteworthy virulence factor is its ability to form a biofilm, which was demonstrated around 1996.<xref ref-type="bibr" rid="article-135131.r38">[38]</xref>&#x000a0;These biofilms consist of a polymeric matrix of polysaccharides, proteins, lipids, nucleic acids, and minimally active bacteria, which can become mature very rapidly, colonizing new surfaces within less than 24 hours.<xref ref-type="bibr" rid="article-135131.r11">[11]</xref><xref ref-type="bibr" rid="article-135131.r38">[38]</xref><xref ref-type="bibr" rid="article-135131.r39">[39]</xref>&#x000a0;The process starts with adherence to the surface, followed by irreversible attachment, then final maturation, and is mediated through its motile flagella, fimbriae/pili, adhesins, and the outer membrane lipopolysaccharide positively charged surface, quorum sensing by diffuse single molecules, and extracellular polymeric substances.<xref ref-type="bibr" rid="article-135131.r8">[8]</xref><xref ref-type="bibr" rid="article-135131.r38">[38]</xref>&#x000a0;This biofilm allows <italic toggle="yes">Stenotrophomonas maltophilia</italic> to firmly adhere to both animate surfaces such as the respiratory epithelial tissue and inanimate surfaces such as ventilation tubes and circuits.<xref ref-type="bibr" rid="article-135131.r2">[2]</xref><xref ref-type="bibr" rid="article-135131.r21">[21]</xref><xref ref-type="bibr" rid="article-135131.r38">[38]</xref>&#x000a0;This enables it to escape the natural human phagocytosis and complement-mediated immune killing defenses, evade the activity of most antibiotics up to a thousand times more, and further spread throughout the surfaces.<xref ref-type="bibr" rid="article-135131.r8">[8]</xref><xref ref-type="bibr" rid="article-135131.r3">[3]</xref><xref ref-type="bibr" rid="article-135131.r26">[26]</xref><xref ref-type="bibr" rid="article-135131.r38">[38]</xref><xref ref-type="bibr" rid="article-135131.r39">[39]</xref>&#x000a0;</p>
        <p>Often, the biofilms are polymicrobial and contain other organisms that benefit from the same advantages. The <italic toggle="yes">spgM</italic> gene was recognized to promote high biofilm production by isolates, along with several other genes.<xref ref-type="bibr" rid="article-135131.r38">[38]</xref><xref ref-type="bibr" rid="article-135131.r40">[40]</xref>&#x000a0;Iron acquisition pathways through siderophore, heme-mediated, and Feo system uptake mechanisms play an essential role in regulating multiple virulence factors, including biofilm formation esp. on iron restriction.<xref ref-type="bibr" rid="article-135131.r41">[41]</xref>&#x000a0;<italic toggle="yes">Stenotrophomonas maltophilia</italic> in biofilms was also shown to tolerate a wide range of pH, nutrient scarcity, and exposure to free radicals.<xref ref-type="bibr" rid="article-135131.r21">[21]</xref></p>
        <p>Second, <italic toggle="yes">Stenotrophomonas maltophilia</italic>&#x000a0;is typically intrinsically resistant to multiple and broad-spectrum antibiotic agents.<xref ref-type="bibr" rid="article-135131.r42">[42]</xref><xref ref-type="bibr" rid="article-135131.r43">[43]</xref>&#x000a0;It shows resistance to most beta-lactams through two inducible enzymes; the class B zinc-dependent penicillinase (L1) and the class A serine cephalosporinase (L2), rendering it resistant to ceftriaxone, piperacillin-tazobactam, and carbapenems.<xref ref-type="bibr" rid="article-135131.r4">[4]</xref><xref ref-type="bibr" rid="article-135131.r18">[18]</xref>&#x000a0;Clavulanic acid has shown activity against the L2 enzyme but not L1.<xref ref-type="bibr" rid="article-135131.r9">[9]</xref>&#x000a0;It also confers resistance to aminoglycosides by its aminoglycoside-modifying acetyl-transferase enzyme.<xref ref-type="bibr" rid="article-135131.r4">[4]</xref>&#x000a0;Several other antimicrobial resistances are achieved through the efflux pumps (for example, the SmeDEF and SmeABC) that act on quinolones, aminoglycosides, macrolides, and tetracyclines.<xref ref-type="bibr" rid="article-135131.r4">[4]</xref><xref ref-type="bibr" rid="article-135131.r18">[18]</xref><xref ref-type="bibr" rid="article-135131.r42">[42]</xref><xref ref-type="bibr" rid="article-135131.r44">[44]</xref>&#x000a0;</p>
        <p>Trimethoprim-sulfamethoxazole resistance is mediated through the target site modification genes <italic toggle="yes">sul1</italic> and&#x000a0;<italic toggle="yes">dfrA</italic> through class 1 integrons, as well as&#x000a0;sul2 gene through insertion sequence common region elements.<xref ref-type="bibr" rid="article-135131.r8">[8]</xref><xref ref-type="bibr" rid="article-135131.r9">[9]</xref>&#x000a0;Another mechanism involves the gyrase and topoisomerase targets of quinolones.<xref ref-type="bibr" rid="article-135131.r4">[4]</xref><xref ref-type="bibr" rid="article-135131.r45">[45]</xref>&#x000a0;Lastly, its outer-membrane lipopolysaccharide shows temperature-dependent structural variation, which confers more resistance to aminoglycosides and polymyxins in particular.<xref ref-type="bibr" rid="article-135131.r2">[2]</xref>&#x000a0;Interestingly, <italic toggle="yes">Stenotrophomonas maltophilia</italic>&#x000a0;can both acquire and transfer antibiotic and heavy metal resistance mechanisms with other pathogens if they co-exist, such as the transfer of the beta-lactamases to previously susceptible Pseudomonas isolates.<xref ref-type="bibr" rid="article-135131.r2">[2]</xref><xref ref-type="bibr" rid="article-135131.r17">[17]</xref><xref ref-type="bibr" rid="article-135131.r46">[46]</xref><xref ref-type="bibr" rid="article-135131.r47">[47]</xref>&#x000a0;This process is referred to as &#x0201c;indirect pathogenicity&#x0201d; and is mediated through integrons, transposons, plasmids, genomic islands, and others.<xref ref-type="bibr" rid="article-135131.r8">[8]</xref><xref ref-type="bibr" rid="article-135131.r48">[48]</xref></p>
        <p>Third, <italic toggle="yes">Stenotrophomonas maltophilia</italic>&#x000a0;utilizes different virulence exoenzymes, such as elastase, gelatinase, hyaluronidase, proteases, lipases, DNase, RNase, and mucinase, for tissue invasion and escaping the host immunity.<xref ref-type="bibr" rid="article-135131.r18">[18]</xref>&#x000a0;Lipases, in particular, are also believed to damage the lipid-rich lung tissues leading to focal lung necrosis and initiating strong inflammatory responses.<xref ref-type="bibr" rid="article-135131.r2">[2]</xref></p>
        <p>Fourth, in chronic infections,&#x000a0;<italic toggle="yes">Stenotrophomonas maltophilia</italic> is capable of forming small-colony variants, which are slowly growing and sometimes challenging to detect.<xref ref-type="bibr" rid="article-135131.r49">[49]</xref></p>
      </sec>
      <sec id="article-135131.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Stenotrophomonas<italic toggle="yes"> maltophilia i</italic>nfections usually occur as a nosocomial infection, though community-acquired infections have also been reported.<xref ref-type="bibr" rid="article-135131.r50">[50]</xref>&#x000a0;One of the challenges with <italic toggle="yes">Stenotrophomonas maltophilia </italic>is that its clinical manifestations are non-specific and almost cannot be distinguished from other infections. As mentioned above, it is, therefore, essential to identify the most vulnerable population to such infection, most importantly the immunocompromised population.<xref ref-type="bibr" rid="article-135131.r51">[51]</xref>&#x000a0;However, one characteristic feature is the late-onset of the related illnesses, which can be about 5 days for hospital-acquired pneumonia and 19 days for bacteremia.<xref ref-type="bibr" rid="article-135131.r52">[52]</xref><xref ref-type="bibr" rid="article-135131.r50">[50]</xref></p>
        <p>It is crucial to differentiate between non-invasive colonization from non-sterile samples and an actual infection that warrants treatment, mainly by the clinical judgment on the symptoms, signs, laboratory, and radiographic evidence of infection.</p>
        <p>The most common isolates were reported from respiratory infections, namely pneumonia cases, whether sputum or bronchioalveolar lavage cultures, at 55% of the total infections.<xref ref-type="bibr" rid="article-135131.r53">[53]</xref><xref ref-type="bibr" rid="article-135131.r38">[38]</xref>&#x000a0;Many times, as mentioned above, it occurs in patients with cystic fibrosis with almost 15% colonization prevalence, tracheostomy patients, or those on mechanical ventilation.<xref ref-type="bibr" rid="article-135131.r9">[9]</xref>&#x000a0;It was also implicated in cases of chronic obstructive pulmonary disease exacerbations.<xref ref-type="bibr" rid="article-135131.r54">[54]</xref>&#x000a0;In certain situations, especially with underlying hematologic malignancies, a fatal fulminant hemorrhagic pneumonia syndrome can occur.<xref ref-type="bibr" rid="article-135131.r55">[55]</xref><xref ref-type="bibr" rid="article-135131.r9">[9]</xref>&#x000a0;Sinopulmonary infections, particularly in neutropenic patients, can raise suspicion for this infection as well.<xref ref-type="bibr" rid="article-135131.r18">[18]</xref></p>
        <p>The second most common form of <italic toggle="yes">Stenotrophomonas maltophilia</italic> infections is bacteremia, at 33% of the infections.<xref ref-type="bibr" rid="article-135131.r38">[38]</xref>&#x000a0;Sometimes the bacteremia is polymicrobial, especially along with <italic toggle="yes">Pseudomonas aeruginosa</italic>, <italic toggle="yes">Acinetobacter baumannii</italic>, and <italic toggle="yes">Enterococcus faecalis.</italic><xref ref-type="bibr" rid="article-135131.r9">[9]</xref><xref ref-type="bibr" rid="article-135131.r56">[56]</xref>&#x000a0;More than 70% of the reported cases were deemed to be central venous catheter-related infections. Recurrence has also been encountered in cases of retained central venous catheters or delayed targeted antibiotics <xref ref-type="bibr" rid="article-135131.r57">[57]</xref>.</p>
        <p>There have been less commonly reported cases of other sites of infection, such as skin and soft tissue infections, at 7.8% of the total infections, most notably wound infections, metastatic cellulitis, and ecthyma gangrenosum.<xref ref-type="bibr" rid="article-135131.r58">[58]</xref>&#x000a0;Others, in no particular order, include meningitis (mostly post-surgery), ocular infections, especially after surface compromise (keratitis, conjunctivitis, endophthalmitis, dacryocystitis, scleral buckle infections, preseptal cellulitis, orbital necrotizing fasciitis, etc.), gingivitis, periodontitis, epiglottitis, sinusitis, otitis externa, mastoiditis, endocarditis, pacemaker infections, intra-abdominal infections (peritonitis, cholangitis, abscesses, enteritis, etc.), urinary tract infections (especially with catheterization and structural abnormalities), epididymitis, septic arthritis, osteochondritis, and bursitis.<xref ref-type="bibr" rid="article-135131.r9">[9]</xref><xref ref-type="bibr" rid="article-135131.r18">[18]</xref><xref ref-type="bibr" rid="article-135131.r59">[59]</xref><xref ref-type="bibr" rid="article-135131.r2">[2]</xref><xref ref-type="bibr" rid="article-135131.r8">[8]</xref><xref ref-type="bibr" rid="article-135131.r60">[60]</xref><xref ref-type="bibr" rid="article-135131.r17">[17]</xref><xref ref-type="bibr" rid="article-135131.r61">[61]</xref></p>
      </sec>
      <sec id="article-135131.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p><italic toggle="yes">Stenotrophomonas maltophilia</italic> easily grows on standard culture media, either as a single isolate or mixed with other culture growths like <italic toggle="yes">Pseudomonas aeruginosa.</italic><xref ref-type="bibr" rid="article-135131.r53">[53]</xref>&#x000a0;Its culture colonies typically are yellow-green in color on nutrient agar, non-hemolytic with a faint lavender color and an ammonia odor on blood agar, and colorless on MacConkey plates since it is non-lactose fermenting.<xref ref-type="bibr" rid="article-135131.r18">[18]</xref><xref ref-type="bibr" rid="article-135131.r17">[17]</xref><xref ref-type="bibr" rid="article-135131.r21">[21]</xref>&#x000a0;It also resembles <italic toggle="yes">Pseudomonas</italic> in having opaque flat surfaces with uneven borders. Selective media were shown to be better in isolating <italic toggle="yes">Stenotrophomonas maltophilia</italic> from non-sterile samples and usually contain imipenem, vancomycin, amphotericin-B, and mannitol/bromothymol blue as an indicator.<xref ref-type="bibr" rid="article-135131.r2">[2]</xref><xref ref-type="bibr" rid="article-135131.r62">[62]</xref><xref ref-type="bibr" rid="article-135131.r3">[3]</xref></p>
        <p>For <italic toggle="yes">in vitro</italic> laboratory identification, <italic toggle="yes">Stenotrophomonas maltophilia</italic> is a strict aerobe that is usually oxidase negative, though it was shown that up to 20% could show positive oxidase activity.<xref ref-type="bibr" rid="article-135131.r17">[17]</xref><xref ref-type="bibr" rid="article-135131.r63">[63]</xref>&#x000a0;It is also catalase-positive, DNase-positive, lysine decarboxylase positive, indole negative, HS negative, and urease negative.<xref ref-type="bibr" rid="article-135131.r4">[4]</xref><xref ref-type="bibr" rid="article-135131.r9">[9]</xref>&#x000a0;It is known to produce acid from maltose, hence the name maltophilia, but not always from glucose.&#x000a0;Many commercial systems are available for identification but are not very accurate.<xref ref-type="bibr" rid="article-135131.r2">[2]</xref>&#x000a0;Therefore, it has been misdiagnosed as <italic toggle="yes">Burkholderia cepacia</italic>-complex, <italic toggle="yes">Achromobacter xylosoxidans</italic>, <italic toggle="yes">Pseudomonas aeruginosa</italic>, and <italic toggle="yes">Bordetella bronchiseptica</italic>&#x000a0;an identification challenge.</p>
        <p>Another diagnostic challenge involves antibiotic susceptibility testing due to difficulties in setting standard minimal inhibitory concentration (MIC) breakpoints for <italic toggle="yes">Stenotrophomonas maltophilia</italic> through different methods.<xref ref-type="bibr" rid="article-135131.r2">[2]</xref>&#x000a0;However, currently, in the U.S., the Clinical and Laboratory Standards Institute (CSLI) has set MICs for trimethoprim-sulfamethoxazole (2 mg/L), levofloxacin, and minocycline by the disc diffusion method, as well as for levofloxacin, ticarcillin-clavulanate, minocycline, ceftazidime, and chloramphenicol by the broth dilution method. Other agents in studies, even in the same classes of these antimicrobials, do not have established breakpoints yet.<xref ref-type="bibr" rid="article-135131.r64">[64]</xref></p>
        <p>Nucleic-acid amplification testing (NAAT) and species-specific 23S rRNA-directed polymerase chain reaction (PCR) techniques are also well used for identification successfully with almost 100% sensitivity and specificity when available.<xref ref-type="bibr" rid="article-135131.r65">[65]</xref><xref ref-type="bibr" rid="article-135131.r66">[66]</xref>&#x000a0;The matrix-assisted laser desorption ionization, time of flight (MALDI-TOF) mass spectrometry has shown good identification as well, in addition to its potential ability to recognize biofilm-producing strains.<xref ref-type="bibr" rid="article-135131.r67">[67]</xref><xref ref-type="bibr" rid="article-135131.r29">[29]</xref>&#x000a0;The use of these rapid methods on samples from critically ill patients can facilitate more rapid use of appropriate antibiotics.<xref ref-type="bibr" rid="article-135131.r9">[9]</xref></p>
        <p>Chest x-rays may reveal lobar or lobular infiltrates in pneumonia cases, either unilateral or bilateral, with uncommon pleural effusions or cavitary lesions on rare occasions.<xref ref-type="bibr" rid="article-135131.r68">[68]</xref></p>
      </sec>
      <sec id="article-135131.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment with specific antibiotics is required when evidence for a true&#x000a0;<italic toggle="yes">Stenotrophomonas maltophilia&#x000a0;</italic>infection is established or in critically sick patients with a <italic toggle="yes">Stenotrophomonas maltophilia</italic> growth until further data are available. Treatment recommendations mostly come from <italic toggle="yes">in vitro</italic> studies, retrospective studies, non-randomized clinical trials, and expert opinions.<xref ref-type="bibr" rid="article-135131.r64">[64]</xref></p>
        <p>The first-line treatment is trimethoprim-sulfamethoxazole, which has been the recommended empiric single agent against <italic toggle="yes">Stenotrophomonas maltophilia</italic> for many years.<xref ref-type="bibr" rid="article-135131.r17">[17]</xref><xref ref-type="bibr" rid="article-135131.r69">[69]</xref>&#x000a0;Given the <italic toggle="yes">in vitro</italic> data suggesting bacteriostatic activity against <italic toggle="yes">Stenotrophomonas maltophilia</italic>, trimethoprim-sulfamethoxazole is recommended at high doses at 15 mg/kg or more of the trimethoprim component, as used for severe <italic toggle="yes">Pneumocystis jirovecii </italic>pneumonia.<xref ref-type="bibr" rid="article-135131.r9">[9]</xref><xref ref-type="bibr" rid="article-135131.r70">[70]</xref>&#x000a0;It has shown activity against more than 90% of the tested isolates in most studies to date, though as mentioned above, resistance has now been increasingly reported at&#x000a0;up to 22-38% in some 21st-century studies.<xref ref-type="bibr" rid="article-135131.r71">[71]</xref><xref ref-type="bibr" rid="article-135131.r72">[72]</xref><xref ref-type="bibr" rid="article-135131.r69">[69]</xref><xref ref-type="bibr" rid="article-135131.r73">[73]</xref><xref ref-type="bibr" rid="article-135131.r74">[74]</xref>&#x000a0;</p>
        <p>One recent study from Mexico showed an 80% resistance rate to trimethoprim/sulfamethoxazole in a combination of environmental and clinical isolates from Mexico.<xref ref-type="bibr" rid="article-135131.r75">[75]</xref>&#x000a0;Also, since trimethoprim-sulfamethoxazole has risks of hypersensitivity, hyperkalemia, deterioration of kidney functions, and bone marrow suppression, those with either a contraindication, intolerance, or adverse events to it must subsequently be treated with another alternative agent, unless there is a chance and benefit from an oral desensitization trial.<xref ref-type="bibr" rid="article-135131.r76">[76]</xref></p>
        <p>Alternatives treatments are the bacteriocidal fluoroquinolones, with up to 80-90% susceptibility rates,&#x000a0;because of their specific biofilm active properties and their high concentration in the lungs.<xref ref-type="bibr" rid="article-135131.r9">[9]</xref><xref ref-type="bibr" rid="article-135131.r4">[4]</xref><xref ref-type="bibr" rid="article-135131.r77">[77]</xref><xref ref-type="bibr" rid="article-135131.r39">[39]</xref><xref ref-type="bibr" rid="article-135131.r17">[17]</xref><xref ref-type="bibr" rid="article-135131.r69">[69]</xref><xref ref-type="bibr" rid="article-135131.r78">[78]</xref>&#x000a0;These include levofloxacin, moxifloxacin, and the newer agents clinafloxacin and rufloxacin (which both showed even better activity than the others), also gatifloxacin, travofloxacin, grepafloxacin, and sparfloxacin.<xref ref-type="bibr" rid="article-135131.r79">[79]</xref><xref ref-type="bibr" rid="article-135131.r80">[80]</xref><xref ref-type="bibr" rid="article-135131.r77">[77]</xref>&#x000a0;Some new studies observed fluoroquinolones susceptibilities down to 73% <xref ref-type="bibr" rid="article-135131.r81">[81]</xref><xref ref-type="bibr" rid="article-135131.r82">[82]</xref><xref ref-type="bibr" rid="article-135131.r69">[69]</xref>. Overall, several studies demonstrated equal effectiveness to trimethoprim/sulfamethoxazole with better fluoroquinolones adverse effects profile.<xref ref-type="bibr" rid="article-135131.r83">[83]</xref><xref ref-type="bibr" rid="article-135131.r84">[84]</xref></p>
        <p>For second-line treatments, minocycline and tigecycline have been reported to have good effectiveness against many isolates at around 80% to 100% susceptibility rate even for isolates resistant to trimethoprim-sulfamethoxazole.<xref ref-type="bibr" rid="article-135131.r85">[85]</xref><xref ref-type="bibr" rid="article-135131.r86">[86]</xref><xref ref-type="bibr" rid="article-135131.r87">[87]</xref><xref ref-type="bibr" rid="article-135131.r88">[88]</xref>&#x000a0;Further, ticarcillin-clavulanic acid has been well studied as one of the effective treatment options for <italic toggle="yes">Stenotrophomonas maltophilia</italic> infections <xref ref-type="bibr" rid="article-135131.r17">[17]</xref>,&#x000a0;with a susceptibility rate ranging from below 50% sometimes to above 80%.<xref ref-type="bibr" rid="article-135131.r64">[64]</xref><xref ref-type="bibr" rid="article-135131.r89">[89]</xref>&#x000a0;Other options include ceftazidime,&#x000a0;though some bodies report it as intrinsically resistant and&#x000a0;with increasing resistance.&#x000a0;Next, colistin is considered a good option&#x000a0;at about a 72% to 77% susceptibility rate.<xref ref-type="bibr" rid="article-135131.r90">[90]</xref>&#x000a0;Another uncommonly used but effective agent is chloramphenicol, with a wide range of susceptibility reports.<xref ref-type="bibr" rid="article-135131.r17">[17]</xref><xref ref-type="bibr" rid="article-135131.r22">[22]</xref></p>
        <p>Resistance to many of these antimicrobials and the co-existence of multiple resistances together are being reported at higher rates in the literature, which creates the need for new agents and regimens to be utilized.<xref ref-type="bibr" rid="article-135131.r69">[69]</xref><xref ref-type="bibr" rid="article-135131.r91">[91]</xref>&#x000a0;Sulfametrole/trimethoprim is an alternative combination to trimethoprim/sulfamethoxazole that was tested and showed good activity in some studies.<xref ref-type="bibr" rid="article-135131.r92">[92]</xref>&#x000a0;Cefiderocol is a new injectable siderophore cephalosporin that has shown promising data against carbapenem-resistant gram-negative bacteria, including <italic toggle="yes">Stenotrophomonas maltophilia.</italic><xref ref-type="bibr" rid="article-135131.r93">[93]</xref><xref ref-type="bibr" rid="article-135131.r94">[94]</xref><xref ref-type="bibr" rid="article-135131.r95">[95]</xref>&#x000a0;</p>
        <p>Eravacycline, omadacycline, and delafloxacin have demonstrated good in-vitro activity as well for their respective infection indications.<xref ref-type="bibr" rid="article-135131.r69">[69]</xref><xref ref-type="bibr" rid="article-135131.r96">[96]</xref><xref ref-type="bibr" rid="article-135131.r97">[97]</xref>&#x000a0;On the other hand, several new antimicrobials like ceftazidime/avibactam, ceftolozane/tazobactam, meropenem/vaborbactam, cilastatin/relebactam, plazomicin, and fosfomycin did not show activity against <italic toggle="yes">Stenotrophomonas</italic>
<italic toggle="yes">maltophilia</italic>&#x000a0;in recent reports.<xref ref-type="bibr" rid="article-135131.r98">[98]</xref><italic toggle="yes">&#x000a0;</italic>Combinations of antimicrobials have been studied with good synergistic promising results, including trimethoprim-sulfamethoxazole/ciprofloxacin, ceftazidime/levofloxacin, ticarcillin-clavulanate/trimethoprim-sulfamethoxazole, ticarcillin-clavulanate/aztreonam, tigecycline/colistin, colistin/rifampicin, ceftazidime/minocycline, levofloxacin/erythromycin, and tigecycline/fosfomycin.<xref ref-type="bibr" rid="article-135131.r99">[99]</xref><xref ref-type="bibr" rid="article-135131.r100">[100]</xref><xref ref-type="bibr" rid="article-135131.r101">[101]</xref><xref ref-type="bibr" rid="article-135131.r102">[102]</xref></p>
        <p>Since some isolates showed resistance to all known tested antimicrobials, new treatment approaches and modalities are currently being studied, such as aerosolized antimicrobials (colistin and levofloxacin), bacteriophage therapy, efflux pump inhibitors, quorum sensing interference (quorum quenching), antimicrobial peptides like the cathelicidin-derived ones, silver or selenium nanoparticles, cationic compounds, plant oils, green tea epigallocatechin-3-gallate, and using <italic toggle="yes">Bdellovivrio exovorus</italic> as a bacterial predator.<xref ref-type="bibr" rid="article-135131.r103">[103]</xref><xref ref-type="bibr" rid="article-135131.r104">[104]</xref><xref ref-type="bibr" rid="article-135131.r105">[105]</xref></p>
        <p>The typical duration of antimicrobial courses for <italic toggle="yes">Stenotrophomonas maltophilia</italic> pneumonia is usually 7 days, which can be extended to 10&#x000a0;to 14 days in immunosuppressed patients. Bacteremia cases, on the other hand, are generally treated for 14 days total.</p>
        <p>Source control is essential in certain cases for successful treatment, such as central venous catheter removal, infected metal hardware retrieval, wounds debridement, conjunctival autografting, and collections drainage.<xref ref-type="bibr" rid="article-135131.r50">[50]</xref><xref ref-type="bibr" rid="article-135131.r59">[59]</xref></p>
      </sec>
      <sec id="article-135131.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Other Stenotrophomonas species typically do not cause infections in humans.</p>
          </list-item>
          <list-item>
            <p>Other gram-negative non-fermenters like <italic toggle="yes">Pseudomonas aeruginosa</italic>, <italic toggle="yes">Acinetobacter baumannii</italic>, <italic toggle="yes">Achromobacter xylosoxidans</italic>, and <italic toggle="yes">Burkholderia cepacia-</italic>complex, can be misidentified as, co-exist with, or be responsible for similar infections to <italic toggle="yes">Stenotrophomonas maltophilia</italic>.</p>
          </list-item>
          <list-item>
            <p>Other more common organisms should be considered first with each infection according to the clinical picture.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-135131.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>There have been controversial data about the high mortality associations with <italic toggle="yes">Stenotrophomonas maltophilia</italic>. The crude mortality rate is estimated to be around 14% to 69% of cases.<xref ref-type="bibr" rid="article-135131.r106">[106]</xref><xref ref-type="bibr" rid="article-135131.r107">[107]</xref>&#x000a0;According to a systematic review, the attributable mortality rate of all <italic toggle="yes">Stenotrophomonas maltophilia</italic> infections was up to 37.5%.<xref ref-type="bibr" rid="article-135131.r108">[108]</xref>&#x000a0;The reported attributable mortality rate in pneumonia cases was at least 20%, while in bacteremia cases was 27%, which was within the same range as other causes of nosocomial bacteremia.<xref ref-type="bibr" rid="article-135131.r109">[109]</xref><xref ref-type="bibr" rid="article-135131.r18">[18]</xref>&#x000a0;</p>
        <p>It was also shown that colonization with <italic toggle="yes">Stenotrophomonas maltophilia</italic> in patients undergoing allogeneic hematopoietic stem cell transplants was associated with significantly higher non-relapse mortality, mainly secondary to severe infections.<xref ref-type="bibr" rid="article-135131.r110">[110]</xref></p>
      </sec>
      <sec id="article-135131.s11" sec-type="Complications">
        <title>Complications</title>
        <p><italic toggle="yes">Stenotrophomonas maltophilia&#x000a0;</italic>outbreaks can occur in hospitals and critical care units.<xref ref-type="bibr" rid="article-135131.r27">[27]</xref>&#x000a0;Biofilm formation leads to the persistence of the bacteria in hospital settings and on equipment.<xref ref-type="bibr" rid="article-135131.r38">[38]</xref></p>
        <p>Infections with <italic toggle="yes">Stenotrophomonas maltophilia</italic> have been associated with worsening lung functions in cystic fibrosis patients.<xref ref-type="bibr" rid="article-135131.r6">[6]</xref><xref ref-type="bibr" rid="article-135131.r111">[111]</xref>&#x000a0;Severe fulminant lung infections can occur in cases of hematologic malignancies.<xref ref-type="bibr" rid="article-135131.r55">[55]</xref></p>
        <p>Bacteremia cases can be complicated by disseminated intravascular coagulopathy (DIC) and purpura fulminans in severe cases.<xref ref-type="bibr" rid="article-135131.r18">[18]</xref>&#x000a0;Recurrence of bacteremia infections occurs when related central venous catheters are not removed or in cases of inappropriate antibiotics.<xref ref-type="bibr" rid="article-135131.r57">[57]</xref></p>
        <p>The aforementioned complications, morbidities, and mortalities, and economic burden highlight the importance of infection prevention.</p>
      </sec>
      <sec id="article-135131.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p><italic toggle="yes">Stenotrophomonas maltophilia</italic> is an intrinsically multidrug-resistant bacteria that usually infects patients with weak immunity. It is often uneasy about treating, given the limited options of antibiotics that can work against it. Always seek your physician&#x02019;s help to answer any questions about this infection since information about it is not readily available to the public. Patients should mention to their provider if&#x000a0;they have allergies to the antibiotic co-trimoxazole since it is usually involved in the treatment.</p>
      </sec>
      <sec id="article-135131.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>All interprofessional healthcare team members need to have good communication&#x000a0;regarding the treatment plan for <italic toggle="yes">Stenotrophomonas maltophilia.</italic>&#x000a0;This includes the clinicians (including mid-level practitioners), residents, infectious diseases consultants, nurses, pharmacists, and the infection prevention team. By coordinating treatment efforts and sharing information about the case, patient outcomes will be improved with fewer adverse events. [Level 5]</p>
        <p>Antibiotic stewardship programs are also critical in preventing and treating&#x000a0;<italic toggle="yes">Stenotrophomonas maltophilia</italic> infections by limiting the unnecessary use of broad-spectrum empiric antimicrobials to the minimum.</p>
        <p>Strict infection prevention measures are also to be implemented and stressed to all team members, including hand hygiene, central venous line insertion precautions, appropriate disposal of potentially contaminated solutions, and proper handling and disinfection of medical equipment.<xref ref-type="bibr" rid="article-135131.r9">[9]</xref><xref ref-type="bibr" rid="article-135131.r8">[8]</xref><xref ref-type="bibr" rid="article-135131.r17">[17]</xref>&#x000a0;Using disinfectants like 3% hydrogen peroxide and 10% peracetic acid has shown to be effective.<xref ref-type="bibr" rid="article-135131.r112">[112]</xref></p>
        <p>Environmental sampling, especially in outbreak situations, is important to identify potential sources. Maintenance of the water supplies, water filtration, and copper-silver ionization for plumbing systems disinfection is recommended to limit the transmission.<xref ref-type="bibr" rid="article-135131.r9">[9]</xref><xref ref-type="bibr" rid="article-135131.r8">[8]</xref><xref ref-type="bibr" rid="article-135131.r17">[17]</xref>&#x000a0;Utilizing new adhesion-resistant materials in medical supplies when made available can also show a positive effect.<xref ref-type="bibr" rid="article-135131.r2">[2]</xref></p>
      </sec>
      <sec id="article-135131.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=135131&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=135131">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/stenotrophomonas-maltophilia/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=135131">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/135131/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=135131">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-135131.s15">
        <title>References</title>
        <ref id="article-135131.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Palleroni</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Bradbury</surname>
                <given-names>JF</given-names>
              </name>
            </person-group>
            <article-title>Stenotrophomonas, a new bacterial genus for Xanthomonas maltophilia (Hugh 1980) Swings et al. 1983.</article-title>
            <source>Int J Syst Bacteriol</source>
            <year>1993</year>
            <month>Jul</month>
            <volume>43</volume>
            <issue>3</issue>
            <fpage>606</fpage>
            <page-range>606-9</page-range>
            <pub-id pub-id-type="pmid">8347518</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Looney</surname>
                <given-names>WJ</given-names>
              </name>
            </person-group>
            <article-title>Role of Stenotrophomonas maltophilia in hospital-acquired infection.</article-title>
            <source>Br J Biomed Sci</source>
            <year>2005</year>
            <volume>62</volume>
            <issue>3</issue>
            <fpage>145</fpage>
            <page-range>145-54; quiz 1 p following 154</page-range>
            <pub-id pub-id-type="pmid">16196464</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pinot</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Deredjian</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nazaret</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Brothier</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Cournoyer</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Segonds</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Favre-Bont&#x000e9;</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Identification of Stenotrophomonas maltophilia strains isolated from environmental and clinical samples: a rapid and efficient procedure.</article-title>
            <source>J Appl Microbiol</source>
            <year>2011</year>
            <month>Nov</month>
            <volume>111</volume>
            <issue>5</issue>
            <fpage>1185</fpage>
            <page-range>1185-93</page-range>
            <pub-id pub-id-type="pmid">21819497</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abbott</surname>
                <given-names>IJ</given-names>
              </name>
              <name>
                <surname>Peleg</surname>
                <given-names>AY</given-names>
              </name>
            </person-group>
            <article-title>Stenotrophomonas, Achromobacter, and nonmelioid Burkholderia species: antimicrobial resistance and therapeutic strategies.</article-title>
            <source>Semin Respir Crit Care Med</source>
            <year>2015</year>
            <month>Feb</month>
            <volume>36</volume>
            <issue>1</issue>
            <fpage>99</fpage>
            <page-range>99-110</page-range>
            <pub-id pub-id-type="pmid">25643274</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Crossman</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Gould</surname>
                <given-names>VC</given-names>
              </name>
              <name>
                <surname>Dow</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Vernikos</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Okazaki</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sebaihia</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Saunders</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Arrowsmith</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Carver</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Peters</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Adlem</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kerhornou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lord</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Seeger</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Squares</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rutter</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Quail</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Rajandream</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Harris</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Churcher</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bentley</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Parkhill</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Thomson</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>Avison</surname>
                <given-names>MB</given-names>
              </name>
            </person-group>
            <article-title>The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants.</article-title>
            <source>Genome Biol</source>
            <year>2008</year>
            <month>Apr</month>
            <day>17</day>
            <volume>9</volume>
            <issue>4</issue>
            <fpage>R74</fpage>
            <pub-id pub-id-type="pmid">18419807</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>An</surname>
                <given-names>SQ</given-names>
              </name>
              <name>
                <surname>Berg</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Stenotrophomonas maltophilia.</article-title>
            <source>Trends Microbiol</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>26</volume>
            <issue>7</issue>
            <fpage>637</fpage>
            <page-range>637-638</page-range>
            <pub-id pub-id-type="pmid">29754971</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Johnson</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Duckworth</surname>
                <given-names>GJ</given-names>
              </name>
            </person-group>
            <article-title>The emergence of Stenotrophomonas maltophilia.</article-title>
            <source>BMJ</source>
            <year>2008</year>
            <month>Jun</month>
            <day>14</day>
            <volume>336</volume>
            <issue>7657</issue>
            <fpage>1322</fpage>
            <pub-id pub-id-type="pmid">18556278</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Looney</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Narita</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>M&#x000fc;hlemann</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Stenotrophomonas maltophilia: an emerging opportunist human pathogen.</article-title>
            <source>Lancet Infect Dis</source>
            <year>2009</year>
            <month>May</month>
            <volume>9</volume>
            <issue>5</issue>
            <fpage>312</fpage>
            <page-range>312-23</page-range>
            <pub-id pub-id-type="pmid">19393961</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abbott</surname>
                <given-names>IJ</given-names>
              </name>
              <name>
                <surname>Slavin</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Turnidge</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Thursky</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Worth</surname>
                <given-names>LJ</given-names>
              </name>
            </person-group>
            <article-title>Stenotrophomonas maltophilia: emerging disease patterns and challenges for treatment.</article-title>
            <source>Expert Rev Anti Infect Ther</source>
            <year>2011</year>
            <month>Apr</month>
            <volume>9</volume>
            <issue>4</issue>
            <fpage>471</fpage>
            <page-range>471-88</page-range>
            <pub-id pub-id-type="pmid">21504403</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brooke</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>New strategies against Stenotrophomonas maltophilia: a serious worldwide intrinsically drug-resistant opportunistic pathogen.</article-title>
            <source>Expert Rev Anti Infect Ther</source>
            <year>2014</year>
            <month>Jan</month>
            <volume>12</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-4</page-range>
            <pub-id pub-id-type="pmid">24308713</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Willsey</surname>
                <given-names>GG</given-names>
              </name>
              <name>
                <surname>Eckstrom</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>LaBauve</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Hinkel</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Schutz</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Meagher</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>LiPuma</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Wargo</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title><italic>Stenotrophomonas maltophilia</italic> Differential Gene Expression in Synthetic Cystic Fibrosis Sputum Reveals Shared and Cystic Fibrosis Strain-Specific Responses to the Sputum Environment.</article-title>
            <source>J Bacteriol</source>
            <year>2019</year>
            <month>Aug</month>
            <day>01</day>
            <volume>201</volume>
            <issue>15</issue>
            <pub-id pub-id-type="pmid">31109991</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bywater</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Casewell</surname>
                <given-names>MW</given-names>
              </name>
            </person-group>
            <article-title>An assessment of the impact of antibiotic resistance in different bacterial species and of the contribution of animal sources to resistance in human infections.</article-title>
            <source>J Antimicrob Chemother</source>
            <year>2000</year>
            <month>Dec</month>
            <volume>46</volume>
            <issue>6</issue>
            <fpage>1052</fpage>
            <pub-id pub-id-type="pmid">11102436</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sader</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>RN</given-names>
              </name>
            </person-group>
            <article-title>Antimicrobial susceptibility of uncommonly isolated non-enteric Gram-negative bacilli.</article-title>
            <source>Int J Antimicrob Agents</source>
            <year>2005</year>
            <month>Feb</month>
            <volume>25</volume>
            <issue>2</issue>
            <fpage>95</fpage>
            <page-range>95-109</page-range>
            <pub-id pub-id-type="pmid">15664479</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Coenye</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Vanlaere</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Falsen</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Vandamme</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Stenotrophomonas africana Drancourt et al. 1997 is a later synonym of Stenotrophomonas maltophilia (Hugh 1981) Palleroni and Bradbury 1993.</article-title>
            <source>Int J Syst Evol Microbiol</source>
            <year>2004</year>
            <month>Jul</month>
            <volume>54</volume>
            <issue>Pt 4</issue>
            <fpage>1235</fpage>
            <page-range>1235-1237</page-range>
            <pub-id pub-id-type="pmid">15280297</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Paez</surname>
                <given-names>JI</given-names>
              </name>
              <name>
                <surname>Tengan</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Barone</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Levin</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Costa</surname>
                <given-names>SF</given-names>
              </name>
            </person-group>
            <article-title>Factors associated with mortality in patients with bloodstream infection and pneumonia due to Stenotrophomonas maltophilia.</article-title>
            <source>Eur J Clin Microbiol Infect Dis</source>
            <year>2008</year>
            <month>Oct</month>
            <volume>27</volume>
            <issue>10</issue>
            <fpage>901</fpage>
            <page-range>901-6</page-range>
            <pub-id pub-id-type="pmid">18483755</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kwa</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Low</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>TP</given-names>
              </name>
              <name>
                <surname>Leow</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Kurup</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tam</surname>
                <given-names>VH</given-names>
              </name>
            </person-group>
            <article-title>Independent predictors for mortality in patients with positive Stenotrophomonas maltophilia cultures.</article-title>
            <source>Ann Acad Med Singap</source>
            <year>2008</year>
            <month>Oct</month>
            <volume>37</volume>
            <issue>10</issue>
            <fpage>826</fpage>
            <page-range>826-30</page-range>
            <pub-id pub-id-type="pmid">19037515</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brooke</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Stenotrophomonas maltophilia: an emerging global opportunistic pathogen.</article-title>
            <source>Clin Microbiol Rev</source>
            <year>2012</year>
            <month>Jan</month>
            <volume>25</volume>
            <issue>1</issue>
            <fpage>2</fpage>
            <page-range>2-41</page-range>
            <pub-id pub-id-type="pmid">22232370</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Senol</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Stenotrophomonas maltophilia: the significance and role as a nosocomial pathogen.</article-title>
            <source>J Hosp Infect</source>
            <year>2004</year>
            <month>May</month>
            <volume>57</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-7</page-range>
            <pub-id pub-id-type="pmid">15142709</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chien</surname>
                <given-names>YC</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Chien</surname>
                <given-names>YC</given-names>
              </name>
            </person-group>
            <article-title>Characteristics of microbial aerosols released from chicken and swine feces.</article-title>
            <source>J Air Waste Manag Assoc</source>
            <year>2011</year>
            <month>Aug</month>
            <volume>61</volume>
            <issue>8</issue>
            <fpage>882</fpage>
            <page-range>882-9</page-range>
            <pub-id pub-id-type="pmid">21874960</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jayol</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Corlouer</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Haenni</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Darty</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Maillard</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Desroches</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lamy</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Jumas-Bilak</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Madec</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Decousser</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Are animals a source of Stenotrophomonas maltophilia in human infections? Contributions of a nationwide molecular study.</article-title>
            <source>Eur J Clin Microbiol Infect Dis</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>37</volume>
            <issue>6</issue>
            <fpage>1039</fpage>
            <page-range>1039-1045</page-range>
            <pub-id pub-id-type="pmid">29488120</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mahdi</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Eklund</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Fisher</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Laboratory culture and maintenance of Stenotrophomonas maltophilia.</article-title>
            <source>Curr Protoc Microbiol</source>
            <year>2014</year>
            <month>Feb</month>
            <day>06</day>
            <volume>32</volume>
            <fpage>Unit 6F.1.</fpage>
            <pub-id pub-id-type="pmid">24510848</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Geiger</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Hogardt</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Heesemann</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Burkholderia/Stenotrophomonas.</article-title>
            <source>Contrib Microbiol</source>
            <year>2001</year>
            <volume>8</volume>
            <fpage>20</fpage>
            <page-range>20-34</page-range>
            <pub-id pub-id-type="pmid">11764736</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mukherjee</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Roy</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Genomic Potential of Stenotrophomonas maltophilia in Bioremediation with an Assessment of Its Multifaceted Role in Our Environment.</article-title>
            <source>Front Microbiol</source>
            <year>2016</year>
            <volume>7</volume>
            <fpage>967</fpage>
            <pub-id pub-id-type="pmid">27446008</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Allen</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Tait</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>M&#x000fc;hling</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Weynberg</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bradley</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Trivedi</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Gharbi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nissimov</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mavromatis</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>CN</given-names>
              </name>
              <name>
                <surname>Grogan</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ali</surname>
                <given-names>ST</given-names>
              </name>
            </person-group>
            <article-title>Genome sequence of Stenotrophomonas maltophilia PML168, which displays Baeyer-Villiger monooxygenase activity.</article-title>
            <source>J Bacteriol</source>
            <year>2012</year>
            <month>Sep</month>
            <volume>194</volume>
            <issue>17</issue>
            <fpage>4753</fpage>
            <page-range>4753-4</page-range>
            <pub-id pub-id-type="pmid">22887661</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weber</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Rutala</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Blanchet</surname>
                <given-names>CN</given-names>
              </name>
              <name>
                <surname>Jordan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gergen</surname>
                <given-names>MF</given-names>
              </name>
            </person-group>
            <article-title>Faucet aerators: A source of patient colonization with Stenotrophomonas maltophilia.</article-title>
            <source>Am J Infect Control</source>
            <year>1999</year>
            <month>Feb</month>
            <volume>27</volume>
            <issue>1</issue>
            <fpage>59</fpage>
            <page-range>59-63</page-range>
            <pub-id pub-id-type="pmid">9949380</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guyot</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Turton</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Garner</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Outbreak of Stenotrophomonas maltophilia on an intensive care unit.</article-title>
            <source>J Hosp Infect</source>
            <year>2013</year>
            <month>Dec</month>
            <volume>85</volume>
            <issue>4</issue>
            <fpage>303</fpage>
            <page-range>303-7</page-range>
            <pub-id pub-id-type="pmid">24148363</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alfieri</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ramotar</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Armstrong</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Spornitz</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Ross</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Winnick</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cook</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>Two consecutive outbreaks of Stenotrophomonas maltophilia (Xanthomonas maltophilia) in an intensive-care unit defined by restriction fragment-length polymorphism typing.</article-title>
            <source>Infect Control Hosp Epidemiol</source>
            <year>1999</year>
            <month>Aug</month>
            <volume>20</volume>
            <issue>8</issue>
            <fpage>553</fpage>
            <page-range>553-6</page-range>
            <pub-id pub-id-type="pmid">10466556</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barchitta</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cipresso</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Giaquinta</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Romeo</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Denaro</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pennisi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Agodi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Acquisition and spread of Acinetobacter baumannii and Stenotrophomonas maltophilia in intensive care patients.</article-title>
            <source>Int J Hyg Environ Health</source>
            <year>2009</year>
            <month>May</month>
            <volume>212</volume>
            <issue>3</issue>
            <fpage>330</fpage>
            <page-range>330-7</page-range>
            <pub-id pub-id-type="pmid">18771951</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Montoya-Hinojosa</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bocanegra-Ibarias</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Garza-Gonz&#x000e1;lez</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Alonso-Ambriz</surname>
                <given-names>&#x000d3;M</given-names>
              </name>
              <name>
                <surname>Salazar-Mata</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Villarreal-Trevi&#x000f1;o</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>P&#x000e9;rez-Alba</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Camacho-Ortiz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Morf&#x000ed;n-Otero</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rodr&#x000ed;guez-Noriega</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Flores-Trevi&#x000f1;o</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Discrimination of biofilm-producing Stenotrophomonas maltophilia clinical strains by matrix-assisted laser desorption ionization-time of flight.</article-title>
            <source>PLoS One</source>
            <year>2020</year>
            <volume>15</volume>
            <issue>12</issue>
            <fpage>e0244751</fpage>
            <pub-id pub-id-type="pmid">33382839</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ryan</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Monchy</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cardinale</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Taghavi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Crossman</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Avison</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Berg</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>van der Lelie</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Dow</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>The versatility and adaptation of bacteria from the genus Stenotrophomonas.</article-title>
            <source>Nat Rev Microbiol</source>
            <year>2009</year>
            <month>Jul</month>
            <volume>7</volume>
            <issue>7</issue>
            <fpage>514</fpage>
            <page-range>514-25</page-range>
            <pub-id pub-id-type="pmid">19528958</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Biagi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Jurkovic</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vialichka</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Meyer</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mendes</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Wenzler</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Activity of Potential Alternative Treatment Agents for Stenotrophomonas maltophilia Isolates Nonsusceptible to Levofloxacin and/or Trimethoprim-Sulfamethoxazole.</article-title>
            <source>J Clin Microbiol</source>
            <year>2020</year>
            <month>Jan</month>
            <day>28</day>
            <volume>58</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">31748318</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Denton</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kerr</surname>
                <given-names>KG</given-names>
              </name>
            </person-group>
            <article-title>Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia.</article-title>
            <source>Clin Microbiol Rev</source>
            <year>1998</year>
            <month>Jan</month>
            <volume>11</volume>
            <issue>1</issue>
            <fpage>57</fpage>
            <page-range>57-80</page-range>
            <pub-id pub-id-type="pmid">9457429</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morrison</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Hoffmann</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Wenzel</surname>
                <given-names>RP</given-names>
              </name>
            </person-group>
            <article-title>Associated mortality and clinical characteristics of nosocomial Pseudomonas maltophilia in a university hospital.</article-title>
            <source>J Clin Microbiol</source>
            <year>1986</year>
            <month>Jul</month>
            <volume>24</volume>
            <issue>1</issue>
            <fpage>52</fpage>
            <page-range>52-5</page-range>
            <pub-id pub-id-type="pmid">3487553</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>del Toro</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Rodr&#x000ed;guez-Bano</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Herrero</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rivero</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a-Ordo&#x000f1;ez</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Corzo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>P&#x000e9;rez-Cano</surname>
                <given-names>R</given-names>
              </name>
              <collab>Grupo Andaluz para el Estudio de las Enfermedades Infecciosas</collab>
            </person-group>
            <article-title>Clinical epidemiology of Stenotrophomonas maltophilia colonization and infection: a multicenter study.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2002</year>
            <month>May</month>
            <volume>81</volume>
            <issue>3</issue>
            <fpage>228</fpage>
            <page-range>228-39</page-range>
            <pub-id pub-id-type="pmid">11997719</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Falagas</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Valkimadi</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>YT</given-names>
              </name>
              <name>
                <surname>Matthaiou</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Hsueh</surname>
                <given-names>PR</given-names>
              </name>
            </person-group>
            <article-title>Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systematic review.</article-title>
            <source>J Antimicrob Chemother</source>
            <year>2008</year>
            <month>Nov</month>
            <volume>62</volume>
            <issue>5</issue>
            <fpage>889</fpage>
            <page-range>889-94</page-range>
            <pub-id pub-id-type="pmid">18662945</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patterson</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Mende</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Carson</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Tribble</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Blyth</surname>
                <given-names>DM</given-names>
              </name>
              <collab>IDCRP TIDOS Group</collab>
            </person-group>
            <article-title>Stenotrophomonas maltophilia infections: Clinical characteristics in a military trauma population.</article-title>
            <source>Diagn Microbiol Infect Dis</source>
            <year>2020</year>
            <month>Feb</month>
            <volume>96</volume>
            <issue>2</issue>
            <fpage>114953</fpage>
            <pub-id pub-id-type="pmid">31791809</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lira</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Berg</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;nez</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Double-Face Meets the Bacterial World: The Opportunistic Pathogen <italic>Stenotrophomonas maltophilia</italic>.</article-title>
            <source>Front Microbiol</source>
            <year>2017</year>
            <volume>8</volume>
            <fpage>2190</fpage>
            <pub-id pub-id-type="pmid">29170656</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Flores-Trevi&#x000f1;o</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bocanegra-Ibarias</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Camacho-Ortiz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Morf&#x000ed;n-Otero</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Salazar-Sesatty</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Garza-Gonz&#x000e1;lez</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title><italic>Stenotrophomonas maltophilia</italic> biofilm: its role in infectious diseases.</article-title>
            <source>Expert Rev Anti Infect Ther</source>
            <year>2019</year>
            <month>Nov</month>
            <volume>17</volume>
            <issue>11</issue>
            <fpage>877</fpage>
            <page-range>877-893</page-range>
            <pub-id pub-id-type="pmid">31658838</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sun</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Liang</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wei</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Lei</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Qi</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Antimicrobial susceptibility of hospital acquired Stenotrophomonas maltophilia isolate biofilms.</article-title>
            <source>Braz J Infect Dis</source>
            <year>2016</year>
            <season>Jul-Aug</season>
            <volume>20</volume>
            <issue>4</issue>
            <fpage>365</fpage>
            <page-range>365-73</page-range>
            <pub-id pub-id-type="pmid">27183359</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pompilio</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pomponio</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Crocetta</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Gherardi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Verginelli</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Fiscarelli</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Dicuonzo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Savini</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>D'Antonio</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Di Bonaventura</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Phenotypic and genotypic characterization of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis: genome diversity, biofilm formation, and virulence.</article-title>
            <source>BMC Microbiol</source>
            <year>2011</year>
            <month>Jul</month>
            <day>05</day>
            <volume>11</volume>
            <fpage>159</fpage>
            <pub-id pub-id-type="pmid">21729271</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kalidasan</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Joseph</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Awang Hamat</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Neela</surname>
                <given-names>VK</given-names>
              </name>
            </person-group>
            <article-title>Iron and Virulence in <italic>Stenotrophomonas Maltophilia</italic>: All We Know So Far.</article-title>
            <source>Front Cell Infect Microbiol</source>
            <year>2018</year>
            <volume>8</volume>
            <fpage>401</fpage>
            <pub-id pub-id-type="pmid">30483485</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Blanco</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Corona</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Martinez</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Mechanisms and phenotypic consequences of acquisition of tigecycline resistance by Stenotrophomonas maltophilia.</article-title>
            <source>J Antimicrob Chemother</source>
            <year>2019</year>
            <month>Nov</month>
            <day>01</day>
            <volume>74</volume>
            <issue>11</issue>
            <fpage>3221</fpage>
            <page-range>3221-3230</page-range>
            <pub-id pub-id-type="pmid">31369109</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>S&#x000e1;nchez</surname>
                <given-names>MB</given-names>
              </name>
            </person-group>
            <article-title>Antibiotic resistance in the opportunistic pathogen Stenotrophomonas maltophilia.</article-title>
            <source>Front Microbiol</source>
            <year>2015</year>
            <volume>6</volume>
            <fpage>658</fpage>
            <pub-id pub-id-type="pmid">26175724</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shah</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>King</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rose</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Medical Management of Endocarditis Caused by <italic>Stenotrophomonas maltophilia</italic>: A Case Report.</article-title>
            <source>J Pharm Pract</source>
            <year>2019</year>
            <month>Dec</month>
            <volume>32</volume>
            <issue>6</issue>
            <fpage>683</fpage>
            <page-range>683-686</page-range>
            <pub-id pub-id-type="pmid">29575970</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>S&#x000e1;nchez</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;nez</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>SmQnr contributes to intrinsic resistance to quinolones in Stenotrophomonas maltophilia.</article-title>
            <source>Antimicrob Agents Chemother</source>
            <year>2010</year>
            <month>Jan</month>
            <volume>54</volume>
            <issue>1</issue>
            <fpage>580</fpage>
            <page-range>580-1</page-range>
            <pub-id pub-id-type="pmid">19841154</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alonso</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sanchez</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;nez</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Stenotrophomonas maltophilia D457R contains a cluster of genes from gram-positive bacteria involved in antibiotic and heavy metal resistance.</article-title>
            <source>Antimicrob Agents Chemother</source>
            <year>2000</year>
            <month>Jul</month>
            <volume>44</volume>
            <issue>7</issue>
            <fpage>1778</fpage>
            <page-range>1778-82</page-range>
            <pub-id pub-id-type="pmid">10858330</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bab&#x000e1;lov&#x000e1;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Blahov&#x000e1;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lesick&#x000e1;-Hupkov&#x000e1;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Krcm&#x000e9;ry</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Kubonov&#x000e1;</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Transfer of ceftazidime and aztreonam resistance from nosocomial strains of Xanthomonas (Stenotrophomonas) maltophilia to a recipient strain of Pseudomonas aeruginosa ML-1008.</article-title>
            <source>Eur J Clin Microbiol Infect Dis</source>
            <year>1995</year>
            <month>Oct</month>
            <volume>14</volume>
            <issue>10</issue>
            <fpage>925</fpage>
            <page-range>925-7</page-range>
            <pub-id pub-id-type="pmid">8605913</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Shen</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Antimicrobial Resistance in <italic>Stenotrophomonas</italic> spp.</article-title>
            <source>Microbiol Spectr</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>6</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">29350131</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Anderson</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Stapp</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Burns</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Qin</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Characterization of small-colony-variant Stenotrophomonas maltophilia isolated from the sputum specimens of five patients with cystic fibrosis.</article-title>
            <source>J Clin Microbiol</source>
            <year>2007</year>
            <month>Feb</month>
            <volume>45</volume>
            <issue>2</issue>
            <fpage>529</fpage>
            <page-range>529-35</page-range>
            <pub-id pub-id-type="pmid">17135443</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Friedman</surname>
                <given-names>ND</given-names>
              </name>
              <name>
                <surname>Korman</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Fairley</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Franklin</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Spelman</surname>
                <given-names>DW</given-names>
              </name>
            </person-group>
            <article-title>Bacteraemia due to Stenotrophomonas maltophilia: an analysis of 45 episodes.</article-title>
            <source>J Infect</source>
            <year>2002</year>
            <month>Jul</month>
            <volume>45</volume>
            <issue>1</issue>
            <fpage>47</fpage>
            <page-range>47-53</page-range>
            <pub-id pub-id-type="pmid">12217732</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hanberger</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Diekema</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Fluit</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Struelens</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Spencer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Wolff</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Surveillance of antibiotic resistance in European ICUs.</article-title>
            <source>J Hosp Infect</source>
            <year>2001</year>
            <month>Jul</month>
            <volume>48</volume>
            <issue>3</issue>
            <fpage>161</fpage>
            <page-range>161-76</page-range>
            <pub-id pub-id-type="pmid">11439002</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mehta</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Niederman</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>Nosocomial pneumonia in the intensive care unit: controversies and dilemmas.</article-title>
            <source>J Intensive Care Med</source>
            <year>2003</year>
            <season>Jul-Aug</season>
            <volume>18</volume>
            <issue>4</issue>
            <fpage>175</fpage>
            <page-range>175-88</page-range>
            <pub-id pub-id-type="pmid">15035764</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kataoka</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Fujiwara</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kawakami</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tanaka</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Tanimoto</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ikawa</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tanaka</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>The indirect pathogenicity of Stenotrophomonas maltophilia.</article-title>
            <source>Int J Antimicrob Agents</source>
            <year>2003</year>
            <month>Dec</month>
            <volume>22</volume>
            <issue>6</issue>
            <fpage>601</fpage>
            <page-range>601-6</page-range>
            <pub-id pub-id-type="pmid">14659658</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nseir</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Di Pompeo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cavestri</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Jozefowicz</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Nyunga</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Soubrier</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Roussel-Delvallez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Saulnier</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Mathieu</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Durocher</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome.</article-title>
            <source>Crit Care Med</source>
            <year>2006</year>
            <month>Dec</month>
            <volume>34</volume>
            <issue>12</issue>
            <fpage>2959</fpage>
            <page-range>2959-66</page-range>
            <pub-id pub-id-type="pmid">17012911</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ort&#x000ed;n</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Jaen-Martinez</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rodr&#x000ed;guez-Luaces</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Alvaro</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Font</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Fatal pulmonary hemorrhage in a patient with myelodysplastic syndrome and fulminant pneumonia caused by Stenotrophomonas maltophilia.</article-title>
            <source>Infection</source>
            <year>2007</year>
            <month>Jun</month>
            <volume>35</volume>
            <issue>3</issue>
            <fpage>201</fpage>
            <page-range>201-2</page-range>
            <pub-id pub-id-type="pmid">17565466</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yeshurun</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gafter-Gvili</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Thaler</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Keller</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Nagler</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shimoni</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Clinical characteristics of Stenotrophomonas maltophilia infection in hematopoietic stem cell transplantation recipients: a single center experience.</article-title>
            <source>Infection</source>
            <year>2010</year>
            <month>Jun</month>
            <volume>38</volume>
            <issue>3</issue>
            <fpage>211</fpage>
            <page-range>211-5</page-range>
            <pub-id pub-id-type="pmid">20425134</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lai</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>WW</given-names>
              </name>
              <name>
                <surname>Chin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>WF</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>KW</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>CY</given-names>
              </name>
            </person-group>
            <article-title>Central venous catheter-related Stenotrophomonas maltophilia bacteraemia and associated relapsing bacteraemia in haematology and oncology patients.</article-title>
            <source>Clin Microbiol Infect</source>
            <year>2006</year>
            <month>Oct</month>
            <volume>12</volume>
            <issue>10</issue>
            <fpage>986</fpage>
            <page-range>986-91</page-range>
            <pub-id pub-id-type="pmid">16961635</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chang</surname>
                <given-names>YT</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Hsueh</surname>
                <given-names>PR</given-names>
              </name>
            </person-group>
            <article-title>Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options.</article-title>
            <source>Front Microbiol</source>
            <year>2015</year>
            <volume>6</volume>
            <fpage>893</fpage>
            <pub-id pub-id-type="pmid">26388847</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>YF</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Hsiao</surname>
                <given-names>CH</given-names>
              </name>
            </person-group>
            <article-title>Stenotrophomonas maltophilia keratitis and scleritis.</article-title>
            <source>Chang Gung Med J</source>
            <year>2005</year>
            <month>Mar</month>
            <volume>28</volume>
            <issue>3</issue>
            <fpage>142</fpage>
            <page-range>142-50</page-range>
            <pub-id pub-id-type="pmid">15945320</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wladis</surname>
                <given-names>EJ</given-names>
              </name>
            </person-group>
            <article-title>Dacryocystitis secondary to Stenotrophomonas maltophilia infection.</article-title>
            <source>Ophthalmic Plast Reconstr Surg</source>
            <year>2011</year>
            <season>Sep-Oct</season>
            <volume>27</volume>
            <issue>5</issue>
            <fpage>e116</fpage>
            <page-range>e116-7</page-range>
            <pub-id pub-id-type="pmid">21178795</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Karan</surname>
                <given-names>NB</given-names>
              </name>
              <name>
                <surname>Kose</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kalyoncu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sekeryapan</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Oter</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Findik</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yurdakul</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Fatal orbital necrotizing fasciitis secondary to stenotrophomonas maltophilia associated stomatitis.</article-title>
            <source>J Stomatol Oral Maxillofac Surg</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>120</volume>
            <issue>3</issue>
            <fpage>260</fpage>
            <page-range>260-262</page-range>
            <pub-id pub-id-type="pmid">30465891</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Denton</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hall</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Todd</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Kerr</surname>
                <given-names>KG</given-names>
              </name>
              <name>
                <surname>Littlewood</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Improved isolation of Stenotrophomonas maltophilia from the sputa of patients with cystic fibrosis using a selective medium.</article-title>
            <source>Clin Microbiol Infect</source>
            <year>2000</year>
            <month>Jul</month>
            <volume>6</volume>
            <issue>7</issue>
            <fpage>397</fpage>
            <page-range>397-8</page-range>
            <pub-id pub-id-type="pmid">11168159</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carmody</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Spilker</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>LiPuma</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Reassessment of Stenotrophomonas maltophilia phenotype.</article-title>
            <source>J Clin Microbiol</source>
            <year>2011</year>
            <month>Mar</month>
            <volume>49</volume>
            <issue>3</issue>
            <fpage>1101</fpage>
            <page-range>1101-3</page-range>
            <pub-id pub-id-type="pmid">21191048</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nicodemo</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Paez</surname>
                <given-names>JI</given-names>
              </name>
            </person-group>
            <article-title>Antimicrobial therapy for Stenotrophomonas maltophilia infections.</article-title>
            <source>Eur J Clin Microbiol Infect Dis</source>
            <year>2007</year>
            <month>Apr</month>
            <volume>26</volume>
            <issue>4</issue>
            <fpage>229</fpage>
            <page-range>229-37</page-range>
            <pub-id pub-id-type="pmid">17334747</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Whitby</surname>
                <given-names>PW</given-names>
              </name>
              <name>
                <surname>Carter</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>Burns</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Royall</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>LiPuma</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Stull</surname>
                <given-names>TL</given-names>
              </name>
            </person-group>
            <article-title>Identification and detection of Stenotrophomonas maltophilia by rRNA-directed PCR.</article-title>
            <source>J Clin Microbiol</source>
            <year>2000</year>
            <month>Dec</month>
            <volume>38</volume>
            <issue>12</issue>
            <fpage>4305</fpage>
            <page-range>4305-9</page-range>
            <pub-id pub-id-type="pmid">11101555</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gallo</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Ramos</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Ferreira</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Oliveira</surname>
                <given-names>SD</given-names>
              </name>
            </person-group>
            <article-title>A specific polymerase chain reaction method to identify Stenotrophomonas maltophilia.</article-title>
            <source>Mem Inst Oswaldo Cruz</source>
            <year>2013</year>
            <month>May</month>
            <volume>108</volume>
            <issue>3</issue>
            <fpage>390</fpage>
            <page-range>390-1</page-range>
            <pub-id pub-id-type="pmid">23778655</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Clark</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Kaleta</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Arora</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wolk</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Matrix-assisted laser desorption ionization-time of flight mass spectrometry: a fundamental shift in the routine practice of clinical microbiology.</article-title>
            <source>Clin Microbiol Rev</source>
            <year>2013</year>
            <month>Jul</month>
            <volume>26</volume>
            <issue>3</issue>
            <fpage>547</fpage>
            <page-range>547-603</page-range>
            <pub-id pub-id-type="pmid">23824373</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vartivarian</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Anaissie</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Kiwan</surname>
                <given-names>EN</given-names>
              </name>
              <name>
                <surname>Papadakis</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <article-title>The clinical spectrum of stenotrophomonas (xanthomonas) maltophilia respiratory infection.</article-title>
            <source>Semin Respir Crit Care Med</source>
            <year>2000</year>
            <volume>21</volume>
            <issue>4</issue>
            <fpage>349</fpage>
            <page-range>349-55</page-range>
            <pub-id pub-id-type="pmid">16088746</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Matson</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Wagner</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Motes</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Bland</surname>
                <given-names>CM</given-names>
              </name>
            </person-group>
            <article-title>Growing resistance in Stenotrophomonas maltophilia?</article-title>
            <source>Am J Health Syst Pharm</source>
            <year>2019</year>
            <month>Dec</month>
            <day>02</day>
            <volume>76</volume>
            <issue>24</issue>
            <fpage>2004</fpage>
            <page-range>2004-2005</page-range>
            <pub-id pub-id-type="pmid">31789358</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vartivarian</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Anaissie</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bodey</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Sprigg</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Rolston</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy.</article-title>
            <source>Antimicrob Agents Chemother</source>
            <year>1994</year>
            <month>Mar</month>
            <volume>38</volume>
            <issue>3</issue>
            <fpage>624</fpage>
            <page-range>624-7</page-range>
            <pub-id pub-id-type="pmid">8203865</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mendes</surname>
                <given-names>ET</given-names>
              </name>
              <name>
                <surname>Paez</surname>
                <given-names>JIG</given-names>
              </name>
              <name>
                <surname>Ferraz</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Marchi</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Silva</surname>
                <given-names>ILAFE</given-names>
              </name>
              <name>
                <surname>Batista</surname>
                <given-names>MV</given-names>
              </name>
              <name>
                <surname>Lima</surname>
                <given-names>ALM</given-names>
              </name>
              <name>
                <surname>Rossi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Levin</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Costa</surname>
                <given-names>SF</given-names>
              </name>
            </person-group>
            <article-title>Clinical and microbiological characteristics of patients colonized or infected by Stenotrophomonas maltophilia : is resistance to sulfamethoxazole/trimethoprim a problem?</article-title>
            <source>Rev Inst Med Trop Sao Paulo</source>
            <year>2020</year>
            <volume>62</volume>
            <fpage>e96</fpage>
            <pub-id pub-id-type="pmid">33295480</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hu</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Kong</surname>
                <given-names>QX</given-names>
              </name>
              <name>
                <surname>Gao</surname>
                <given-names>LP</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Ye</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>JB</given-names>
              </name>
            </person-group>
            <article-title>Increase in the Prevalence of Resistance Determinants to Trimethoprim/Sulfamethoxazole in Clinical Stenotrophomonas maltophilia Isolates in China.</article-title>
            <source>PLoS One</source>
            <year>2016</year>
            <volume>11</volume>
            <issue>6</issue>
            <fpage>e0157693</fpage>
            <pub-id pub-id-type="pmid">27310255</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Milne</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Gould</surname>
                <given-names>IM</given-names>
              </name>
            </person-group>
            <article-title>Combination antimicrobial susceptibility testing of multidrug-resistant Stenotrophomonas maltophilia from cystic fibrosis patients.</article-title>
            <source>Antimicrob Agents Chemother</source>
            <year>2012</year>
            <month>Aug</month>
            <volume>56</volume>
            <issue>8</issue>
            <fpage>4071</fpage>
            <page-range>4071-7</page-range>
            <pub-id pub-id-type="pmid">22585220</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r74">
          <label>74</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Church</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lloyd</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Peirano</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Pitout</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Antimicrobial susceptibility and combination testing of invasive Stenotrophomonas maltophilia isolates.</article-title>
            <source>Scand J Infect Dis</source>
            <year>2013</year>
            <month>Apr</month>
            <volume>45</volume>
            <issue>4</issue>
            <fpage>265</fpage>
            <page-range>265-70</page-range>
            <pub-id pub-id-type="pmid">23113657</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r75">
          <label>75</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Elufisan</surname>
                <given-names>TO</given-names>
              </name>
              <name>
                <surname>Luna</surname>
                <given-names>ICR</given-names>
              </name>
              <name>
                <surname>Oyedara</surname>
                <given-names>OO</given-names>
              </name>
              <name>
                <surname>Varela</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a</surname>
                <given-names>VB</given-names>
              </name>
              <name>
                <surname>Oluyide</surname>
                <given-names>BO</given-names>
              </name>
              <name>
                <surname>Trevi&#x000f1;o</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>L&#x000f3;pez</surname>
                <given-names>MAV</given-names>
              </name>
              <name>
                <surname>Guo</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Antimicrobial susceptibility pattern of <italic>Stenotrophomonas</italic> species isolated from Mexico.</article-title>
            <source>Afr Health Sci</source>
            <year>2020</year>
            <month>Mar</month>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>168</fpage>
            <page-range>168-181</page-range>
            <pub-id pub-id-type="pmid">33402905</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r76">
          <label>76</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yilmaz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Celik</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Mert</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Successfully treated nosocomial Stenotrophomonas maltophilia bacteremia following desensitization to trimethoprim-sulfamethoxazole.</article-title>
            <source>J Infect Chemother</source>
            <year>2007</year>
            <month>Apr</month>
            <volume>13</volume>
            <issue>2</issue>
            <fpage>122</fpage>
            <page-range>122-3</page-range>
            <pub-id pub-id-type="pmid">17458682</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r77">
          <label>77</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Di Bonaventura</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Spedicato</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>D'Antonio</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Robuffo</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Piccolomini</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Biofilm formation by Stenotrophomonas maltophilia: modulation by quinolones, trimethoprim-sulfamethoxazole, and ceftazidime.</article-title>
            <source>Antimicrob Agents Chemother</source>
            <year>2004</year>
            <month>Jan</month>
            <volume>48</volume>
            <issue>1</issue>
            <fpage>151</fpage>
            <page-range>151-60</page-range>
            <pub-id pub-id-type="pmid">14693533</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r78">
          <label>78</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adegoke</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Stenstr&#x000f6;m</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Okoh</surname>
                <given-names>AI</given-names>
              </name>
            </person-group>
            <article-title><italic>Stenotrophomonas maltophilia</italic> as an Emerging Ubiquitous Pathogen: Looking Beyond Contemporary Antibiotic Therapy.</article-title>
            <source>Front Microbiol</source>
            <year>2017</year>
            <volume>8</volume>
            <fpage>2276</fpage>
            <pub-id pub-id-type="pmid">29250041</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r79">
          <label>79</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weiss</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Restieri</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>De Carolis</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Laverdi&#x000e8;re</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Guay</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Comparative activity of new quinolones against 326 clinical isolates of Stenotrophomonas maltophilia.</article-title>
            <source>J Antimicrob Chemother</source>
            <year>2000</year>
            <month>Mar</month>
            <volume>45</volume>
            <issue>3</issue>
            <fpage>363</fpage>
            <page-range>363-5</page-range>
            <pub-id pub-id-type="pmid">10702558</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r80">
          <label>80</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pankuch</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Jacobs</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Appelbaum</surname>
                <given-names>PC</given-names>
              </name>
            </person-group>
            <article-title>Susceptibilities of 123 Xanthomonas maltophilia strains to clinafloxacin, PD 131628, PD 138312, PD 140248, ciprofloxacin, and ofloxacin.</article-title>
            <source>Antimicrob Agents Chemother</source>
            <year>1994</year>
            <month>Feb</month>
            <volume>38</volume>
            <issue>2</issue>
            <fpage>369</fpage>
            <page-range>369-70</page-range>
            <pub-id pub-id-type="pmid">8192468</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r81">
          <label>81</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>YS</given-names>
              </name>
              <name>
                <surname>Toh</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>YL</given-names>
              </name>
              <name>
                <surname>Ho</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Ko</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Tang</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>KW</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>YC</given-names>
              </name>
              <name>
                <surname>Chuang</surname>
                <given-names>YC</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ni</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Hsueh</surname>
                <given-names>PR</given-names>
              </name>
            </person-group>
            <article-title>In vitro susceptibilities of non-Enterobacteriaceae isolates from patients with intra-abdominal infections in the Asia-Pacific region from 2003 to 2010: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART).</article-title>
            <source>Int J Antimicrob Agents</source>
            <year>2012</year>
            <month>Jun</month>
            <volume>40 Suppl</volume>
            <fpage>S11</fpage>
            <page-range>S11-7</page-range>
            <pub-id pub-id-type="pmid">22749053</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r82">
          <label>82</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sader</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Flamm</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>RN</given-names>
              </name>
            </person-group>
            <article-title>Tigecycline activity tested against antimicrobial resistant surveillance subsets of clinical bacteria collected worldwide (2011).</article-title>
            <source>Diagn Microbiol Infect Dis</source>
            <year>2013</year>
            <month>Jun</month>
            <volume>76</volume>
            <issue>2</issue>
            <fpage>217</fpage>
            <page-range>217-21</page-range>
            <pub-id pub-id-type="pmid">23522845</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r83">
          <label>83</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>YL</given-names>
              </name>
              <name>
                <surname>Scipione</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Dubrovskaya</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Papadopoulos</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Monotherapy with fluoroquinolone or trimethoprim-sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections.</article-title>
            <source>Antimicrob Agents Chemother</source>
            <year>2014</year>
            <volume>58</volume>
            <issue>1</issue>
            <fpage>176</fpage>
            <page-range>176-82</page-range>
            <pub-id pub-id-type="pmid">24145530</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r84">
          <label>84</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Watson</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Esterly</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>AO</given-names>
              </name>
              <name>
                <surname>Postelnick</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Aguirre</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>McLaughlin</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Sulfamethoxazole/trimethoprim versus fluoroquinolones for the treatment of Stenotrophomonas maltophilia bloodstream infections.</article-title>
            <source>J Glob Antimicrob Resist</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>12</volume>
            <fpage>104</fpage>
            <page-range>104-106</page-range>
            <pub-id pub-id-type="pmid">28964955</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r85">
          <label>85</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Flamm</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Shortridge</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Castanheira</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sader</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Pfaller</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title><italic>In Vitro</italic> Activity of Minocycline against U.S. Isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus Species Complex, Stenotrophomonas maltophilia, and Burkholderia cepacia Complex: Results from the SENTRY Antimicrobial Surveillance Program, 2014 to 2018.</article-title>
            <source>Antimicrob Agents Chemother</source>
            <year>2019</year>
            <month>Nov</month>
            <volume>63</volume>
            <issue>11</issue>
            <pub-id pub-id-type="pmid">31427295</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r86">
          <label>86</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jacobson</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Junco Noa</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Bowman</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Clinical outcomes using minocycline for Stenotrophomonas maltophilia infections.</article-title>
            <source>J Antimicrob Chemother</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>71</volume>
            <issue>12</issue>
            <fpage>3620</fpage>
            <pub-id pub-id-type="pmid">27516472</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r87">
          <label>87</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Castanheira</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mendes</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>RN</given-names>
              </name>
            </person-group>
            <article-title>Update on Acinetobacter species: mechanisms of antimicrobial resistance and contemporary in vitro activity of minocycline and other treatment options.</article-title>
            <source>Clin Infect Dis</source>
            <year>2014</year>
            <month>Dec</month>
            <day>01</day>
            <volume>59 Suppl 6</volume>
            <fpage>S367</fpage>
            <page-range>S367-73</page-range>
            <pub-id pub-id-type="pmid">25371512</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r88">
          <label>88</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sader</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Farrell</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Flamm</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>RN</given-names>
              </name>
            </person-group>
            <article-title>Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalised with pneumonia in US and European hospitals: results from the SENTRY Antimicrobial Surveillance Program, 2009-2012.</article-title>
            <source>Int J Antimicrob Agents</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>43</volume>
            <issue>4</issue>
            <fpage>328</fpage>
            <page-range>328-34</page-range>
            <pub-id pub-id-type="pmid">24630306</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r89">
          <label>89</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nicodemo</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Araujo</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Ruiz</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Gales</surname>
                <given-names>AC</given-names>
              </name>
            </person-group>
            <article-title>In vitro susceptibility of Stenotrophomonas maltophilia isolates: comparison of disc diffusion, Etest and agar dilution methods.</article-title>
            <source>J Antimicrob Chemother</source>
            <year>2004</year>
            <month>Apr</month>
            <volume>53</volume>
            <issue>4</issue>
            <fpage>604</fpage>
            <page-range>604-8</page-range>
            <pub-id pub-id-type="pmid">14973153</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r90">
          <label>90</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gales</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Reis</surname>
                <given-names>AO</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>RN</given-names>
              </name>
            </person-group>
            <article-title>Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines.</article-title>
            <source>J Clin Microbiol</source>
            <year>2001</year>
            <month>Jan</month>
            <volume>39</volume>
            <issue>1</issue>
            <fpage>183</fpage>
            <page-range>183-90</page-range>
            <pub-id pub-id-type="pmid">11136768</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r91">
          <label>91</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tsiodras</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pittet</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Carmeli</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Eliopoulos</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Boucher</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Harbarth</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Clinical implications of stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: a study of 69 patients at 2 university hospitals.</article-title>
            <source>Scand J Infect Dis</source>
            <year>2000</year>
            <volume>32</volume>
            <issue>6</issue>
            <fpage>651</fpage>
            <page-range>651-6</page-range>
            <pub-id pub-id-type="pmid">11200376</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r92">
          <label>92</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Livermore</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Mushtaq</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Warner</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Woodford</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Comparative in vitro activity of sulfametrole/trimethoprim and sulfamethoxazole/trimethoprim and other agents against multiresistant Gram-negative bacteria.</article-title>
            <source>J Antimicrob Chemother</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>69</volume>
            <issue>4</issue>
            <fpage>1050</fpage>
            <page-range>1050-6</page-range>
            <pub-id pub-id-type="pmid">24257317</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r93">
          <label>93</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhanel</surname>
                <given-names>GG</given-names>
              </name>
              <name>
                <surname>Golden</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Zelenitsky</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wiebe</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lawrence</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Adam</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Idowu</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Domalaon</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Schweizer</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Zhanel</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Lagac&#x000e9;-Wiens</surname>
                <given-names>PRS</given-names>
              </name>
              <name>
                <surname>Walkty</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Noreddin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lynch Iii</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Karlowsky</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.</article-title>
            <source>Drugs</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>79</volume>
            <issue>3</issue>
            <fpage>271</fpage>
            <page-range>271-289</page-range>
            <pub-id pub-id-type="pmid">30712199</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r94">
          <label>94</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kish</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>New Antibiotics in Development Target Highly Resistant Gram-Negative Organisms.</article-title>
            <source>P T</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>43</volume>
            <issue>2</issue>
            <fpage>116</fpage>
            <page-range>116-120</page-range>
            <pub-id pub-id-type="pmid">29386869</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r95">
          <label>95</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hackel</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Tsuji</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yamano</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Echols</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Karlowsky</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Sahm</surname>
                <given-names>DF</given-names>
              </name>
            </person-group>
            <article-title><italic>In Vitro</italic> Activity of the Siderophore Cephalosporin, Cefiderocol, against Carbapenem-Nonsusceptible and Multidrug-Resistant Isolates of Gram-Negative Bacilli Collected Worldwide in 2014 to 2016.</article-title>
            <source>Antimicrob Agents Chemother</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>62</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">29158270</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r96">
          <label>96</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pfaller</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Huband</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Rhomberg</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Flamm</surname>
                <given-names>RK</given-names>
              </name>
            </person-group>
            <article-title>Surveillance of Omadacycline Activity against Clinical Isolates from a Global Collection (North America, Europe, Latin America, Asia-Western Pacific), 2010-2011.</article-title>
            <source>Antimicrob Agents Chemother</source>
            <year>2017</year>
            <month>May</month>
            <volume>61</volume>
            <issue>5</issue>
            <pub-id pub-id-type="pmid">28223386</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r97">
          <label>97</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Almer</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Hoffrage</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Keller</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Flamm</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Shortridge</surname>
                <given-names>VD</given-names>
              </name>
            </person-group>
            <article-title>In vitro and bactericidal activities of ABT-492, a novel fluoroquinolone, against Gram-positive and Gram-negative organisms.</article-title>
            <source>Antimicrob Agents Chemother</source>
            <year>2004</year>
            <month>Jul</month>
            <volume>48</volume>
            <issue>7</issue>
            <fpage>2771</fpage>
            <page-range>2771-7</page-range>
            <pub-id pub-id-type="pmid">15215148</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r98">
          <label>98</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Doi</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Treatment Options for Carbapenem-resistant Gram-negative Bacterial Infections.</article-title>
            <source>Clin Infect Dis</source>
            <year>2019</year>
            <month>Nov</month>
            <day>13</day>
            <volume>69</volume>
            <issue>Suppl 7</issue>
            <fpage>S565</fpage>
            <page-range>S565-S575</page-range>
            <pub-id pub-id-type="pmid">31724043</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r99">
          <label>99</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gibson</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Burns</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Ramsey</surname>
                <given-names>BW</given-names>
              </name>
            </person-group>
            <article-title>Pathophysiology and management of pulmonary infections in cystic fibrosis.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>2003</year>
            <month>Oct</month>
            <day>15</day>
            <volume>168</volume>
            <issue>8</issue>
            <fpage>918</fpage>
            <page-range>918-51</page-range>
            <pub-id pub-id-type="pmid">14555458</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r100">
          <label>100</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hu</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>Gao</surname>
                <given-names>LP</given-names>
              </name>
              <name>
                <surname>Ye</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>XT</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>HF</given-names>
              </name>
              <name>
                <surname>Liiu</surname>
                <given-names>YY</given-names>
              </name>
              <name>
                <surname>Mei</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>JB</given-names>
              </name>
            </person-group>
            <article-title>Susceptibility of Stenotrophomonas maltophilia clinical strains in China to antimicrobial combinations.</article-title>
            <source>J Chemother</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>26</volume>
            <issue>5</issue>
            <fpage>282</fpage>
            <page-range>282-6</page-range>
            <pub-id pub-id-type="pmid">24588423</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r101">
          <label>101</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Betts</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Phee</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Woodford</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Wareham</surname>
                <given-names>DW</given-names>
              </name>
            </person-group>
            <article-title>Activity of colistin in combination with tigecycline or rifampicin against multidrug-resistant Stenotrophomonas maltophilia.</article-title>
            <source>Eur J Clin Microbiol Infect Dis</source>
            <year>2014</year>
            <month>Sep</month>
            <volume>33</volume>
            <issue>9</issue>
            <fpage>1565</fpage>
            <page-range>1565-72</page-range>
            <pub-id pub-id-type="pmid">24781003</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r102">
          <label>102</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rojas</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Garcia</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Calder&#x000f3;n</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Ferreira</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Rosso</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Successful treatment of Stenotrophomonas maltophilia meningitis in a preterm baby boy: a case report.</article-title>
            <source>J Med Case Rep</source>
            <year>2009</year>
            <month>Jul</month>
            <day>17</day>
            <volume>3</volume>
            <fpage>7389</fpage>
            <pub-id pub-id-type="pmid">19830198</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r103">
          <label>103</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Geller</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Flume</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Griffith</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Morgan</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Loutit</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Dudley</surname>
                <given-names>MN</given-names>
              </name>
            </person-group>
            <article-title>Pharmacokinetics and safety of MP-376 (levofloxacin inhalation solution) in cystic fibrosis subjects.</article-title>
            <source>Antimicrob Agents Chemother</source>
            <year>2011</year>
            <month>Jun</month>
            <volume>55</volume>
            <issue>6</issue>
            <fpage>2636</fpage>
            <page-range>2636-40</page-range>
            <pub-id pub-id-type="pmid">21444699</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r104">
          <label>104</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gil-Gil</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;nez</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Blanco</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Mechanisms of antimicrobial resistance in <italic>Stenotrophomonas maltophilia</italic>: a review of current knowledge.</article-title>
            <source>Expert Rev Anti Infect Ther</source>
            <year>2020</year>
            <month>Apr</month>
            <volume>18</volume>
            <issue>4</issue>
            <fpage>335</fpage>
            <page-range>335-347</page-range>
            <pub-id pub-id-type="pmid">32052662</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r105">
          <label>105</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Defoirdt</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Quorum-Sensing Systems as Targets for Antivirulence Therapy.</article-title>
            <source>Trends Microbiol</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>26</volume>
            <issue>4</issue>
            <fpage>313</fpage>
            <page-range>313-328</page-range>
            <pub-id pub-id-type="pmid">29132819</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r106">
          <label>106</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Senol</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>DesJardin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Stark</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Barefoot</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Snydman</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>Attributable mortality of Stenotrophomonas maltophilia bacteremia.</article-title>
            <source>Clin Infect Dis</source>
            <year>2002</year>
            <month>Jun</month>
            <day>15</day>
            <volume>34</volume>
            <issue>12</issue>
            <fpage>1653</fpage>
            <page-range>1653-6</page-range>
            <pub-id pub-id-type="pmid">12032905</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r107">
          <label>107</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Muder</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Harris</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Muller</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Edmond</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chow</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Papadakis</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Wagener</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Bodey</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Steckelberg</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Bacteremia due to Stenotrophomonas (Xanthomonas) maltophilia: a prospective, multicenter study of 91 episodes.</article-title>
            <source>Clin Infect Dis</source>
            <year>1996</year>
            <month>Mar</month>
            <volume>22</volume>
            <issue>3</issue>
            <fpage>508</fpage>
            <page-range>508-12</page-range>
            <pub-id pub-id-type="pmid">8852971</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r108">
          <label>108</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Falagas</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Kastoris</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Vouloumanou</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Rafailidis</surname>
                <given-names>PI</given-names>
              </name>
              <name>
                <surname>Kapaskelis</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Dimopoulos</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Attributable mortality of Stenotrophomonas maltophilia infections: a systematic review of the literature.</article-title>
            <source>Future Microbiol</source>
            <year>2009</year>
            <month>Nov</month>
            <volume>4</volume>
            <issue>9</issue>
            <fpage>1103</fpage>
            <page-range>1103-9</page-range>
            <pub-id pub-id-type="pmid">19895214</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r109">
          <label>109</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aisenberg</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Rolston</surname>
                <given-names>KV</given-names>
              </name>
              <name>
                <surname>Dickey</surname>
                <given-names>BF</given-names>
              </name>
              <name>
                <surname>Kontoyiannis</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Raad</surname>
                <given-names>II</given-names>
              </name>
              <name>
                <surname>Safdar</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Stenotrophomonas maltophilia pneumonia in cancer patients without traditional risk factors for infection, 1997-2004.</article-title>
            <source>Eur J Clin Microbiol Infect Dis</source>
            <year>2007</year>
            <month>Jan</month>
            <volume>26</volume>
            <issue>1</issue>
            <fpage>13</fpage>
            <page-range>13-20</page-range>
            <pub-id pub-id-type="pmid">17200840</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r110">
          <label>110</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hanes</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Demirkan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tolley</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Boucher</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Croce</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Wood</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Fabian</surname>
                <given-names>TC</given-names>
              </name>
            </person-group>
            <article-title>Risk factors for late-onset nosocomial pneumonia caused by Stenotrophomonas maltophilia in critically ill trauma patients.</article-title>
            <source>Clin Infect Dis</source>
            <year>2002</year>
            <month>Aug</month>
            <day>01</day>
            <volume>35</volume>
            <issue>3</issue>
            <fpage>228</fpage>
            <page-range>228-35</page-range>
            <pub-id pub-id-type="pmid">12115086</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r111">
          <label>111</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Waters</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Yau</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Prasad</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Atenafu</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Crandall</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Tom</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tullis</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ratjen</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Stenotrophomonas maltophilia in cystic fibrosis: serologic response and effect on lung disease.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>2011</year>
            <month>Mar</month>
            <day>01</day>
            <volume>183</volume>
            <issue>5</issue>
            <fpage>635</fpage>
            <page-range>635-40</page-range>
            <pub-id pub-id-type="pmid">20889901</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135131.r112">
          <label>112</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sacchetti</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>De Luca</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Zanetti</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Control of Pseudomonas aeruginosa and Stenotrophomonas maltophilia contamination of microfiltered water dispensers with peracetic acid and hydrogen peroxide.</article-title>
            <source>Int J Food Microbiol</source>
            <year>2009</year>
            <month>Jun</month>
            <day>30</day>
            <volume>132</volume>
            <issue>2-3</issue>
            <fpage>162</fpage>
            <page-range>162-6</page-range>
            <pub-id pub-id-type="pmid">19439386</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
